The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 492-497

  Shindo, Michiko ^a   Arai, Ken ^a   Okuno, Tadao ^a  

^a Akashi Municipal Hospital   (Japan)

Author keywords

chronic hepatitis C; grading and staging scoring system; predictors of a long term response

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HISTOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 0031052005     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80412-6     Document Type: Article

References (23)

1. Desmet V, Gerber M, Hoofnagle JH, Mann M, Scheuer P. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
2. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H. Histological grading and staging of chronic hepatitis. J Hepatol. 22:1995;696-699.
3. Hytiroglou P, Thung SN, Gerber MA. Histological classification and quantitation of the severity of chronic hepatitis: keep it simple! Semin Liver Dis. 15:1995;414-421.
4. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
5. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada N. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology. 104:1993;877-883.
6. Balart LA, Perrillo R, Roddenberry J, Regenstein F, Shim K-S, Shieh YSC, Gerber M. Hepatitis C RNA in liver of chronic C patients before and after interferon alpha treatment. Gastroenterology. 104:1993;1472-1477.
7. Davis GL, Lindsay K, Albrecht J, Bodenheimer HC, Balart LA, Perrillo RP. Predictors of response to recombinant alpha interferon treatment in patients with chronic hepatitis C. Hepatology. 12:1990;905.
8. Tsubota A, Chayama K, Ikeda Y, Yasuji A, Koida I, Saitoh S, Kumada H. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology. 19:1994;1088-1094.
9. Serfaty L, Giral P, Loria A, Andreani T, Legendre C, Poupon. Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol. 21:1994;12-17.
10. Camps J, Garcia-Granero M, Riezu-Boj JI, Larrea E, De Alava E, Civeira MP, Prieto J. Prediction of sustained remission of chronic hepatitis C after 12-month course of alpha interferon. J Hepatol. 21:1994;4-11.
11. Kanai K, Kato M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet. 339:1992;1543.
12. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 16:1992;293-299.
13. Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol. 21:1994;1-3.
14. Shindo M, Arai K, Sokawa Y, Okuno T. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy. Ann Intern Med. 122:1995;586-591.
15. Fong TL, Shindo M, Feinstone SM, Hoofnagle JH, Di Bisceglie AM. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest. 88:1991;1058-1060.
16. Shindo M, Di Bisceglie AM, Biswas R, Mihalik K, Feinstone SM. Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis. 166:1992;424-427.
17. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
18. Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH. Decrease in serum hepatitis C viral RNA in serum during alpha-interferon therapy for chronic hepatitis. Ann Intern Med. 115:1991;700-704.
19. Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, Mayumi M. The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med. 60:1990;167-177.
20. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 339:1989;237-238.
21. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 73:1992;673-679.
22. Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med. 324:1991;933-940.
23. Camps J, Castilla A, Ruiz J, Civeira MP, Prieto J. Randomized trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia. J Hepatol. 17:1993;390-396.